Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 117

1.

Significant impact of electrical storm on mortality in patients with structural heart disease and an implantable cardiac defibrillator.

Noda T, Kurita T, Nitta T, Chiba Y, Furushima H, Matsumoto N, Toyoshima T, Shimizu A, Mitamura H, Okumura K, Ohe T, Aizawa Y.

Int J Cardiol. 2018 Mar 15;255:85-91. doi: 10.1016/j.ijcard.2017.11.077.

2.

Heart Failure and Sudden Cardiac Death.

Saour B, Smith B, Yancy CW.

Card Electrophysiol Clin. 2017 Dec;9(4):709-723. doi: 10.1016/j.ccep.2017.07.010. Review.

PMID:
29173412
3.

Usefulness of Speckle Tracking Strain Echocardiography for Assessment of Risk of Ventricular Arrhythmias After Placement of a Left Ventricular Assist Device.

Akhabue E, Seok Park C, Pinney S, Anyanwu A, Chaudhry F, Narula J, Nair A, Sengupta PP.

Am J Cardiol. 2017 Nov 1;120(9):1578-1583. doi: 10.1016/j.amjcard.2017.07.056. Epub 2017 Jul 31.

PMID:
28882335
4.

Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry: The EFFORTLESS Study.

Boersma L, Barr C, Knops R, Theuns D, Eckardt L, Neuzil P, Scholten M, Hood M, Kuschyk J, Jones P, Duffy E, Husby M, Stein K, Lambiase PD; EFFORTLESS Investigator Group.

J Am Coll Cardiol. 2017 Aug 15;70(7):830-841. doi: 10.1016/j.jacc.2017.06.040.

5.

Management of Implantable Cardioverter Defibrillator Recipients: Care Beyond Guidelines.

Philippon F, Sterns LD, Nery PB, Parkash R, Birnie D, Rinne C, Mondesert B, Exner D, Bennett M.

Can J Cardiol. 2017 Aug;33(8):977-990. doi: 10.1016/j.cjca.2017.05.012. Epub 2017 May 26. Review.

PMID:
28754398
6.

Totally Leadless Dual-Device Implantation for Combined Spontaneous Ventricular Tachycardia Defibrillation and Pacemaker Function: A First Report.

Ahmed FZ, Cunnington C, Motwani M, Zaidi AM.

Can J Cardiol. 2017 Aug;33(8):1066.e5-1066.e7. doi: 10.1016/j.cjca.2017.05.017. Epub 2017 May 30.

PMID:
28754393
7.

Usefulness of Left Atrial Emptying Fraction to Predict Ventricular Arrhythmias in Patients With Implantable Cardioverter Defibrillators.

Rijnierse MT, Kamali Sadeghian M, Schuurmans Stekhoven S, Biesbroek PS, van der Lingen AC, van de Ven PM, van Rossum AC, Nijveldt R, Allaart CP.

Am J Cardiol. 2017 Jul 15;120(2):243-250. doi: 10.1016/j.amjcard.2017.04.015. Epub 2017 Apr 27.

8.

Multicenter investigation of an implantable cardioverter-defibrillator algorithm to detect oversensing.

Welte N, Strik M, Eschalier R, Mondoly P, Defaye P, Frontera A, Ritter P, Haïssaguerre M, Ploux S, Koneru J, Ellenbogen KA, Bordachar P.

Heart Rhythm. 2017 Jul;14(7):1008-1015. doi: 10.1016/j.hrthm.2017.03.023. Epub 2017 Mar 18.

PMID:
28323174
9.

Results of a curtailed randomized controlled trial, evaluating the efficacy and safety of azimilide in patients with implantable cardioverter-defibrillators: The SHIELD-2 trial.

Robinson VM, Bharucha DB, Mahaffey KW, Dorian P, Kowey PR; SHIELD-2 Investigators.

Am Heart J. 2017 Mar;185:43-51. doi: 10.1016/j.ahj.2016.10.025. Epub 2016 Nov 15.

10.

The subcutaneous ICD as an alternative to the conventional ICD system: Initial experience in Greece and a review of the literature.

Sideris S, Archontakis S, Gatzoulis KA, Anastasakis A, Sotiropoulos I, Arsenos P, Kasiakogias A, Terentes D, Trachanas K, Paschalidis E, Tousoulis D, Kallikazaros I.

Hellenic J Cardiol. 2017 Jan - Feb;58(1):4-16. doi: 10.1016/j.hjc.2017.01.010. Epub 2017 Feb 2. Review.

11.

Electrical treatment of atrial arrhythmias in heart failure patients implanted with a dual defibrillator CRT device. Results from the TRADE-HF study.

Botto GL, Padeletti L, Covino G, Pieragnoli P, Liccardo M, Mariconti B, Favale S, Molon G, De Filippo P, Bolognese L, Landolina M, Raciti G, Boriani G.

Int J Cardiol. 2017 Jun 1;236:181-186. doi: 10.1016/j.ijcard.2017.01.101. Epub 2017 Jan 19.

PMID:
28131706
12.

Cardiac Pacemakers: Function, Troubleshooting, and Management: Part 1 of a 2-Part Series.

Mulpuru SK, Madhavan M, McLeod CJ, Cha YM, Friedman PA.

J Am Coll Cardiol. 2017 Jan 17;69(2):189-210. doi: 10.1016/j.jacc.2016.10.061. Review.

13.

Performance of the subcutaneous implantable cardioverter-defibrillator in patients with a primary prevention indication with and without a reduced ejection fraction versus patients with a secondary prevention indication.

Boersma LV, Barr CS, Burke MC, Leon AR, Theuns DA, Herre JM, Weiss R, Kremers MS, Neuzil P, Husby MP, Carter N, Stivland TM, Gold MR; EFFORTLESS and IDE Study Investigators.

Heart Rhythm. 2017 Mar;14(3):367-375. doi: 10.1016/j.hrthm.2016.11.025. Epub 2016 Nov 24.

14.

Differences in the onset mode of ventricular tachyarrhythmia between patients with J wave in anterior leads and those with J wave in inferolateral leads.

Kamakura T, Wada M, Ishibashi K, Inoue YY, Miyamoto K, Okamura H, Nagase S, Noda T, Aiba T, Yasuda S, Shimizu W, Kamakura S, Kusano K.

Heart Rhythm. 2017 Apr;14(4):553-561. doi: 10.1016/j.hrthm.2016.11.027. Epub 2016 Nov 23.

PMID:
27890733
15.

Apical hypertrophic cardiomyopathy with hemodynamically unstable ventricular arrhythmia - Atypical presentation.

Chaturvedi H, Pandey RD, Sharma KK, Makkar JS, Sharma SK.

Indian Heart J. 2016 Sep;68 Suppl 2:S202-S206. doi: 10.1016/j.ihj.2015.08.011. Epub 2016 Jan 14.

16.

Sudden cardiac death: A reappraisal.

Steinberg C, Laksman ZW, Krahn AD.

Trends Cardiovasc Med. 2016 Nov;26(8):709-719. doi: 10.1016/j.tcm.2016.05.006. Epub 2016 May 21. Review.

PMID:
27665048
17.

Prognostic Value of Late Gadolinium Enhancement in Nonischemic Cardiomyopathy.

Gaztanaga J, Paruchuri V, Elias E, Wilner J, Islam S, Sawit S, Viles-Gonzalez J, Sanz J, Garcia MJ.

Am J Cardiol. 2016 Oct 1;118(7):1063-8. doi: 10.1016/j.amjcard.2016.06.059. Epub 2016 Jul 18.

PMID:
27614850
18.

Efficacy and limitations of treatment of ventricular fibrillation/ventricular tachycardia storm by subcutaneous implantable cardioverter defibrillator.

Nagra B, Awan MU, Miriyala V, Kantharia BK.

Int J Cardiol. 2016 Nov 1;222:978-979. doi: 10.1016/j.ijcard.2016.08.103. Epub 2016 Aug 7. No abstract available.

PMID:
27529389
19.

Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator Implantation to Prevent Tachyarrhythmias following Acute Myocardial Infarction (PROTECT-ICD): Trial Protocol, Background and Significance.

Zaman S, Taylor AJ, Stiles M, Chow C, Kovoor P.

Heart Lung Circ. 2016 Nov;25(11):1055-1062. doi: 10.1016/j.hlc.2016.04.007. Epub 2016 May 6. Review.

PMID:
27522511
20.

A Comparison of the Quality of Life of Patients With an Entirely Subcutaneous Implantable Defibrillator System Versus a Transvenous System (from the EFFORTLESS S-ICD Quality of Life Substudy).

Pedersen SS, Mastenbroek MH, Carter N, Barr C, Neuzil P, Scholten M, Lambiase PD, Boersma L, Johansen JB, Theuns DA.

Am J Cardiol. 2016 Aug 15;118(4):520-6. doi: 10.1016/j.amjcard.2016.05.047. Epub 2016 May 28.

PMID:
27353211

Supplemental Content

Loading ...
Support Center